thyroid medication and glp 1 glp-1 cancer risk No Increased for in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin Semaglutide: What we know about – GLP-1 Therapy with Thyroid Conditions

In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)

This notion implies that, although favorable results have been reported for clinical studies, the paucity of existing data warrants the need for further ventures in order to further elucidate the favorable effects of GLP-1 in heart failure patients [82]

Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis

Gao, Z., Wei, Y

Back 'The journey to understanding incretin systems: Theory, practice and more theory', Journal of Diabetes Investigation , 10/5